Clinical Trials List
2009-12-01 - 2012-12-31
Phase II
Terminated8
-
Trial Applicant
Daiichi Sankyo Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chiun Hsu 無
- YU-YUN SHAO Division of Hematology & Oncology
- 林宗哲 無
- Chih-Hung Hsu 無
- - - 無
- PEI-JER CHEN 無
- Ying-Chun Shen 無
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ting-Tsung Chang 無
- 吳毅晉 無
- Pin-Nan Cheng 無
- Yih-Jyh Lin 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 黃文聰 無
- Shang-Wen Chen 無
- 陳威宇 無
- 林明賢 無
- 林正耀 無
- 吳志順 無
- 林建良 無
- 馮盈勳 無
- 陳昭勳 無
- Shang-Hung Chen 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chen-Chun Lin 無
- Tsai-Sheng Yang 無
- 林淳榮 無
- Chun-Yen Lin 無
- 林宗男 無
- 陳威廷 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 紀廣明 無
- 曾亮節 無
- Jing-Houng Wang 無
- 盧勝男 無
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ming-Lun Yeh Digestive System Department
- Zu-Yau Lin Digestive System Department
- Shinn-Cherng Chen Digestive System Department
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
48 participants
-
Global
177 participants
